BIOGEN INC. (BIIB) 13F Holdings

Healthcare · Biological Products, (No Diagnostic Substances)

Institutional ownership and 13F holdings context for BIOGEN INC. (BIIB) on InvestAtlant.

Top institutional holders (2026-Q3)

InstitutionSharesValue% Outstanding
GEODE CAPITAL MANAGEMENT, LLC 4,507,404 .01B 3.05%
Amundi 1,316,534 $297.38M 0.89%
DIMENSIONAL FUND ADVISORS LP 1,158,052 $261.59M 0.78%
DEUTSCHE BANK AG\ 864,971 95.38M 0.59%
Pictet Asset Management Holding SA 832,444 88.23M 0.56%
Bank of New York Mellon Corp 759,838 71.63M 0.51%
CITIGROUP INC 746,858 68.70M 0.51%
Robeco Institutional Asset Management B.V. 656,465 48.28M 0.44%

US equities research

Follow the money behind the market.

Public filings. Connected research. One workspace.

Click a source to open it in the workspace

InvestAtlant connects public filings, institutional activity, insider trades, congressional disclosures, and sector data to surface emerging market signals.

Signals

Where the market starts to move.

Detect emerging patterns, convergence, and divergence before they become obvious.

How it works

Three steps. From data to insight.

  1. Find

    Research stocks, investors, sectors, and politicians.

  2. Track

    Follow capital flows across sectors and filings.

  3. Detect

    Spot emerging alignment and divergence.

Fundamentals · Market context · Institutions · Insiders · Sectors · SEC filings

Open the research workspace.

Holdings from SEC 13F. Insider trades from Form 4. Congress from House and Senate PTRs. Real-time market prices via TradingView.